In vivo osteoinductivity of gelatin β-tri-calcium phosphate sponge and bone morphogenetic protein-2 on an equine third metacarpal bone defect

Research in Veterinary Science

Volumn 93, Issue 2, 2012, Pages 1021-1025

  Tsuzuki, N ^a   Otsuka, K ^a   Seo, J ^a   Yamada, K ^a   Haneda, S ^a   Furuoka, H ^a   Tabata, Y ^b   Sasaki, N ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein 2; Equine; Gelatin tri calcium phosphate sponge

Indexed keywords

CALCIUM PHOSPHATE; FIBROBLAST GROWTH FACTOR 2; GELATIN BETA TRICALCIUM PHOSPHATE SPONGE; GELATIN SPONGE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE RADIOGRAPHY; BONE REGENERATION; CONTROLLED STUDY; FEMALE; HISTOLOGY; HORSE; HYDROGEL; METACARPAL BONE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CALCIUM PHOSPHATES; FEMALE; FORELIMB; GELATIN; HORSES; OSTEOGENESIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EQUIDAE;

EID: 84863099299     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2011.12.002     Document Type: Article

References (24)

1. Asamura S., Mochizuki Y., Yamamoto M., Tabata Y., Isogai N. Bone regeneration using a bone morphogenetic protein-2 saturated slow-release gelatin hydrogel sheet. Annals of Plastic Surgery 2010, 64:496-502.
2. Bernstein A., Mayr H.O., Hube R. Can bone healing in distraction osteogenesis be accelerated by local application of IGF-1 and TGF-β1?. Journal of Biomedical Materials Research, Part B: Applied Biomaterials 2010, 92:215-225.
3. Dimmen S., Nordsletten L., Madsen J.E. Parecoxib and indomethacin delay early fracture healing. Clinical Orthopaedics and Related Research 2009, 467:1992-1999.
4. Gittens S., Uludag H. Growth factor delivery for bone tissue engineering. Journal of Drug Targeting 2001, 9:407-429.
5. Gomez G., Korkiakoski S., Gonzalez M.M., Lansman S., Ella V., Salo T., Kellomaki M., Ashammakhi N., Arnaud E. Effect of FGF and polylactide scaffolds on calvarial bone healing with growth factor on biodegradable polymer scaffolds. Journal of Craniofacial Surgery 2006, 17:935-942.
6. Graham S., Leonidou A., Lester M., Heliotis M., Mantalaris A., Tsiridis E. Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opinion in Investigating Drugs 2009, 18:1633-1654.
7. Ishihara A., Kathleen M., Litsky A., Mattoon J.S., Weisbrode S.E., Bartlett J.S., Bertone A.L. Osteogenic gene regulation and relative acceleration of healing by adenoviral-mediated transfer of human BMP-2 or -6 in equine osteotomy and ostectomy models. Journal of Orthopaedic Research 2008, 26:764-771.
8. Kawaguchi H., Oka H., Jingushi S., Izumi T., Fukunaga M., Sato K., Matsushita T., Nakamura K. A local application of recombinant human fibroblast growth factor-2 for tibial shaft fractures: A randomized, placebo-controlled trial. Journal of Bone and Mineral Research 2010, 25:2735-2743.
9. Lieberman J., Daluiski A., Einhorn T.A. The role of growth factors in the repair of bone. Journal of Bone and Joint Surgery. American Volume 2002, 84:1032-1044.
10. Macdonald K.K., Cheung C.Y., Anseth K. Cellular delivery of TGFbeta1 promotes osteoinductive signalling for bone regeneration. Journal of Tissue Engineering Regenerative Medicine 2007, 1:314-317.
11. Matsumoto G., Omi Y., Kubota E., Ozono S., Tsuzuki H., Kinoshita Y., Yamamoto M., Tabata Y. Enhanced regeneration of ritical bone defects using a biodegradable gelatin sponge and 2-tricalcium phosphate with bone morphogenetic protein-2. Journal of Biomaterials Applications 2009, 24:327-342.
12. Miyazaki M., Morishita Y., He W., Hu M., Shintuu C., Hymanson H.J., Falakassa J., Tsumura H., Wang J.C. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats. Spine Journal 2009, 9:22-30.
13. Moore D.C., Enrlich M.G., McAllister S.C., Machan J.T., Hart C.E., Voigt C., Lesieur-Brooks A.M., Weber E.W. Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis. Journal of Bone and Joint Surgery. American Volume 2009, 91:1973-1984.
14. Perrier M., Lu Y., Brett N., Kobayashi H., Peterson A., Markel M. Acceleration of second and fourth metatarsal fracture healing with recombinant human bone morphogenetic protein-2/calcium phosphate cement in horses. Veterinary Surgery 2008, 37:648-655.
15. Reiff D.A., Kelpke S., Rue L., Tompson J.A. Acidic fibroblast growth factor attenuates the cytotoxic effects of peroxynitrite in primary human osteoblast precursors. Journal of Trauma 2001, 50:433-438.
16. Sasaki N., Minami T., Yamada K., Yamada H., Inoue Y., Kobayashi M., Tabata Y. In vivo effects of intra-articular injection of gelatin hydrogen microspheres containing basic fibroblast growth factor on experimentally induced defects in third metacarpal bones of horses. American Journal of Veterinary Research 2008, 69:1555-1559.
17. Smith E.L., Locke M., Waddington R.J., Sloan A.J. An ex vivo rodent mandible culture model for bone repair. Tissue Engineering Part C Methods 2010, 16:1287-1296.
18. Sohier J., Daculsi G., Sourice S., Groot K., Pierre L. Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering. Journal of Biomedical Materials Research 2010, 92:1105-1114.
19. Tabata Y., Yamada K., Miyamoto S., Nagata I., Kikuchi H., Aoyama I., Tamura M., Ikada Y. Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials 1998, 19:807-815.
20. Takahashi Y., Yamamoto M., Tabata Y. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate. Biomaterials 2005, 26:4856-4865.
21. Takahashi Y., Yamamoto M., Yamada K., Kawakami O., Tabata Y. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Engineering 2007, 13:293-300.
22. Tanaka E., Ishino Y., Sasaki A., Hasegawa T., Watanabe M., Dalla-Bona D.A., Yamano E., Eijden T.M.G.J., Tanne K. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity. Annals of Biomedical Engineering 2006, 34:717-725.
23. Wong W.C.F., Yu Y., Wallace A.L., Gianoutsos M.P., Sonnabend D.H., Walsh W.R. Use of a polymeric device to deliver growth factors to a healing fracture. ANZ Journal of Surgery 2003, 73:1022-1027.
24. Xiao L., Sobue T., Esliger A., Kronenberg M.S., Coffin J.D., Doetschman T., Hurley M.M. Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells. Bone 2010, 47:360-370.